Accessibility Menu

Prestige Consumer Healthcare(FRA) PBV

Market Cap€2.05BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPON/A
5 YearN/A
1 YearN/A
1 MonthN/A
€44.00
+1.85%
+0.80Today

Prestige Consumer Healthcare Financials at a Glance

Market Cap

€2.05BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

€947.32

Net Income (TTM)

€147.43

EPS (TTM)

€3.06

P/E Ratio

14.11

Dividend

€0.00

Beta (Volatility)

-0.05 (Low)

Price

€44.00

Volume

0

Open

€44.00

Previous Close

€43.20

Daily Range

€44.00 - €44.00

52-Week Range

€38.00 - €60.00

Estimated Earnings Date

N/A

PBV News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Prestige Consumer Healthcare

Prestige Consumer Healthcare, Inc. engages in the marketing, sale, and distribution of pharmaceutical drugs and consumer products. It operates through the following segments: North American OTC Healthcare and International OTC Healthcare. The North American and International OTC Healthcare segments manages the following brands: BC/Goody's, Beano, Boudreaux's Butt Paste, Chloraseptic, Clear Eyes, Compound W, Debrox, DenTek, Dramamine, Efferdent, Fess, Fleet, Gaviscon, Hydralyte, Luden's, Monistat, Nix, Pedia-Lax, and Summer's Eve. The company was founded in 1996 and is headquartered in Tarrytown, NY.

Industry

Pharmaceuticals

Sector

Health Care

Employees

890

CEO

Ronald M. Lombardi, MBA, CPA

Website

www.prestigebrands.com

PBV Financials

Key Financial Metrics (TTM)

Gross Margin

N/A

Operating Margin

N/A

Net Income Margin

N/A

Return on Equity

9.05%

Return on Capital

N/A

Return on Assets

N/A

Earnings Yield

7.09%

Dividend Yield

0.00%

Payout Ratio

N/A

Stock Overview

Market Cap

€2.05BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

47.37M

Volume

0

Avg. Volume

0.576

Financials (TTM)

Gross Profit

N/A

Operating Income

N/A

EBITDA

N/A

Operating Cash Flow

N/A

Capital Expenditure

N/A

Free Cash Flow

N/A

Cash & ST Invst.

N/A

Total Debt

N/A

Prestige Consumer Healthcare Performance Analysis

Prestige Consumer Healthcare annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20232023-03-31EUR 1,084,117,35315.9%
20242024-03-31EUR 1,037,913,219-4.3%
20252025-03-31EUR 1,059,804,7882.1%
20262026-03-31EUR 939,573,202-11.3%
Prestige Consumer Healthcare annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20232023-03-31EUR -1.59N/A
20242024-03-31EUR 3.85N/A
20252025-03-31EUR 3.993.7%
20262026-03-31EUR 3.37-15.5%

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q2 2026YOY CHG

Revenue

€228.53

+1.0%

Gross Profit

€112.23

+0.9%

Gross Margin

49.11%

+0.9%

Market Cap

€2.05BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

€2.17

N/A

Employees

890

N/A

Net Income

€25.09

+0.6%

EBITDA

€52.70

+0.8%

Quarterly Fundamentals

Name
Q2 2026YOY CHG

Total Cash

€1.89K

+87.3%

Total Debt

€1.81K

+2.0%

Accounts Receivable

€163.87

+1.1%

Inventory

€166.37

+1.3%

Long Term Debt

€1.79K

+2.0%

Short Term Debt

€20.82

+2.8%

Return on Assets

4.26%

+0.7%

Return on Invested Capital

4.96%

N/A

Free Cash Flow

€57.70

+0.8%

Operating Cash Flow

€60.88

+0.9%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
^GSPCS&P 500
$7,684.24-0.00%
^DJIDJI
$53,254.61-0.01%
^IXICNASDAQ
$26,319.55-0.00%
BTCBitcoin
$78,890.00-0.00%

Trending Stocks

Symbol / CompanyPricePrice Chg
TQQQProShares Trust - ProShares UltraPro Qqq
$71.92+0.00%
WETOWetour Robotics
$5.48-0.04%
IBITiShares Bitcoin Trust
$44.67+0.02%
INTCIntel
$89.51+0.00%

Questions About PBV

What is the current price of Prestige Consumer Healthcare?

Prestige Consumer Healthcare is trading at €44.00 per share.

What is the 52-week range for Prestige Consumer Healthcare?

Over the past 52 weeks, Prestige Consumer Healthcare has traded between €38.00 and €60.00.

How much debt does Prestige Consumer Healthcare have?

As of the most recent reporting period, Prestige Consumer Healthcare reported total debt of €1.81B.

How much cash does Prestige Consumer Healthcare have on hand?

Prestige Consumer Healthcare reported €77.96M in cash and cash equivalents in its most recent financial results.

What is Prestige Consumer Healthcare’s dividend yield?

Prestige Consumer Healthcare does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.

View Premium Services